International Clinical Trial: Efficacy and safetfy of Alfacalcidol in the treatment of severe fever with thrombocytopenia syndsrome

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128894) titled 'Efficacy and safetfy of Alfacalcidol in the treatment of severe fever with thrombocytopenia syndsrome' on July 28.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Ditan Hospital, Capital Medical University

Condition: severe fever with thrombocytopenia syndrome

Intervention: Test group:Administer alfacalcidol to the patient orally.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Test group:144;Control group:144;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=3345...